Expansion and manipulation of natural killer cells in patients with metastatic cancer by low-dose continuous infusion and intermittent bolus administration of interleukin 2.
Year: 1996
Type: article
Study design: Clinical Trial
Source: PubMed
Authors: R J Soiffer, C Murray, C Shapiro, H Collins, S Chartier, S Lazo, J Ritz
Institutions: Harvard University, Dana-Farber Cancer Institute
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
Funder: National Institutes of Health
OpenAlex ID: W2159647567
